Abstract
Get full access to this article
View all access options for this article.
References
1.FDA approves dabrafenib plus trametinib for anaplastic thyroid cancer with BRAF V600E mutation . Available at: https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm606708.htm (accessed
September 1 , 2018
).
2.
Wu
CW
,
Chiang
FY
,
Randolph
GW
,
Dionigi
G
,
Kim
HY
,
Lin
YC
,
Huang
TY
,
Lin
CI
,
Hun
PC
,
Kamani
D
,
Chang
PY
,
Lu
IC
. 2018 . Transcutaneous recording during intraoperative neuromonitoring in thyroid surgery . Thyroid , 28 :1500 –1507 .
3.
Wu
CW
,
Chiang
FY
,
Randolph
GW
,
Dionigi
G
,
Kim
HY
,
Lin
YC
,
Chen
HC
,
Chen
HY
,
Kamani
D
,
Tsai
TY
,
Lu
IC
,
Chang
PY
. 2018 . Feasibility of intraoperative neuromonitoring during thyroid surgery using transcartilage surface recording electrodes . Thyroid , 28 :1508 –1516 .
4.
Thomas
G
,
McWade
MA
,
Paras
C
,
Mannoh
EA
,
Sanders
ME
,
White
LM
,
Broome
JT
,
Phay
JE
,
Baregamian
N
,
Solorzano
CC
,
Mahadevan-Jansen
A
. 2018 . Developing a clinical prototype to guide surgeons for intraoperative label-free identification of parathyroid glands in real time . Thyroid , 28 :1517 –1531 .